Synthesis of radioiodinated N-succinimidyl iodobenzoate: Optimization for use in antibody labelling
β Scribed by Pradeep K. Garg; Gerald E. Archer Jr; Darell D. Bigner; Michael R. Zalutsky
- Publisher
- Elsevier Science
- Year
- 1989
- Weight
- 408 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0883-2889
No coin nor oath required. For personal study only.
β¦ Synopsis
N-succinimidyl-3-(tri-n-butylstannyl)benzoate (m-BuATE), N-succinimidyl-3-(tri-methylstannyl)benzoate (m-MeATE) and N-succinimidyl-4-(tri-n-butylstannyl)benzoate (p-BuATE) were synthesized and radioiodinated using either N-chlorosuccinimide (NCS) or t-butylhydroperoxide (TBHP) as the oxidant. Radiohalogenation of m-MeATE proceeded more rapidly than m-BuATE. NCS was the more efficient oxidant at reaction times less than 15 min; use of both TBHP and NCS resulted in nearly quantitative yields after 15 min when m-MeATE was used. Using NCS, achieving optimal antibody coupling and specific binding required purification of the active ester by HPLC; in contrast, with TBHP, only Sep-Pak purification was needed.
π SIMILAR VOLUMES
## Abstract Sumitriptan (1), a nonβselective 5βHT~1B/1D~ agonist is an effective therapeutic agent for the acute treatment of migraine, but it is contraindicated for use in patients with known heart disease. The first Selective Serotonin One F Receptor Agonist (SSOFRA), 5β(4β²βfluorobenzβamido)β3β(_